Portfolio company
Amplified Sciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops molecular diagnostic tests and sensing platforms to help clinicians detect and monitor pancreatic cancer and other serious diseases in patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AgendX
The company develops molecular diagnostic tests to detect pancreatic cancer for healthcare providers and patients.
BillionToOne
This company develops molecular diagnostic tests for prenatal screening and oncology care to help clinicians and patients identify genetic conditions and monitor cancer.
Molecular Stethoscope
This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.
Amadix
This company develops blood-based liquid biopsy tests for the early detection of colorectal, lung and pancreatic cancer in patients and healthcare settings.
AgenDx Biosciences
This company develops a molecular diagnostics platform to provide cost-effective cancer and infectious disease testing for clinical settings and healthcare providers.
Veracyte
This company develops genomic tests and diagnostic tools to help clinicians and patients make informed treatment decisions for various types of cancer.
Oncobit
This company develops precision diagnostic assays and cloud-based monitoring software for clinicians to track cancer markers and therapy response in oncology patients.
Amplifyer Bio
This company develops humanised priming agents that increase circulating tumour DNA recovery to improve liquid biopsy sensitivity for cancer diagnostic providers.
